$CMND Up 59% Premarket! 🚀 🔹 Clearmind Medicine is a clinical-stage biotech developing non-hallucinogenic psychedelic-derived therapeutics 🔹 Recent catalyst:

$CMND Up 59% Premarket! 🚀 🔹 Clearmind Medicine is a clinical-stage biotech developing non-hallucinogenic psychedelic-derived therapeutics 🔹 Recent catalyst: 20 participants now treated in its ongoing Phase I/IIa CMND-100 trial for Alcohol Use Disorder 👀 🔹 CMND-100 previously met its primary end…